Sponsor:
Celgene
Code:
NCT01688011
Conditions
Primary Myelofibrosis
Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luspatercept
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by Celgene on 2024-05-02.